GANX News and Press, Gain Therapeutics Inc. From 11/20/23

2023-11-20 16:08:32 ET More on Gain Therapeutics Seeking Alpha’s Quant Rating on Gain Therapeutics Historical earnings data for Gain Therapeutics Financial information for Gain Therapeutics For further details see: Gain Therapeutics intends to offe...

2023-11-14 09:02:00 ET More on Gain Therapeutics Seeking Alpha’s Quant Rating on Gain Therapeutics Historical earnings data for Gain Therapeutics Financial information for Gain Therapeutics For further details see: Gain Therapeutics GAAP EPS of -$0.37

BETHESDA, Md., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announc...

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

Gain Therapeutics Inc. (GANX) is expected to report $-0.47 for Q3 2023

2023-10-04 09:46:09 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Apple (NASDAQ: AAPL ) stock is a hot topic among traders on Wednesday after several insiders in the tech giant sold shares. One thing that traders will keep in mind is that ...

2023-10-04 09:11:28 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nvni Group (NASDAQ: NVNI ) stock is falling on Wednesday after the company recently made its public debut following a special purpose acquisition company (SPAC) merger. ...

2023-10-04 08:45:07 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Gain Therapeutics (NASDAQ: GANX ) stock is on the move Wednesday as investors react to updated clinical trial news from the company. According to a press release from Ga...

BETHESDA, Md., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announc...

BETHESDA, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (the “Company”), a biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that the Company’s Chief Exec...